BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30896738)

  • 1. The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant Neoplasms.
    Dixon PR; Tomlinson G; Pasternak JD; Mete O; Bell CM; Sawka AM; Goldstein DP; Urbach DR
    JAMA Oncol; 2019 Jun; 5(6):817-823. PubMed ID: 30896738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment.
    Nickel B; Howard K; Brito JP; Barratt A; Moynihan R; McCaffery K
    JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):887-896. PubMed ID: 30140909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Preferences Around Extent of Surgery in Low-Risk Thyroid Cancer: A Discrete Choice Experiment.
    Ahmadi S; Gonzalez JM; Talbott M; Reed SD; Yang JC; Scheri RP; Stang M; Roman S; Sosa JA
    Thyroid; 2020 Jul; 30(7):1044-1052. PubMed ID: 32143553
    [No Abstract]   [Full Text] [Related]  

  • 4. How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment.
    Marshall DA; Deal K; Bombard Y; Leighl N; MacDonald KV; Trudeau M
    BMJ Open; 2016 Jun; 6(6):e010981. PubMed ID: 27256091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' Preferences for the Treatment of Metastatic Castrate-resistant Prostate Cancer: A Discrete Choice Experiment.
    Eliasson L; de Freitas HM; Dearden L; Calimlim B; Lloyd AJ
    Clin Ther; 2017 Apr; 39(4):723-737. PubMed ID: 28366592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Experience of Thyroid Cancer Active Surveillance in Japan.
    Davies L; Roman BR; Fukushima M; Ito Y; Miyauchi A
    JAMA Otolaryngol Head Neck Surg; 2019 Apr; 145(4):363-370. PubMed ID: 30703198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of Cosmetic Concerns on Patient Preferences for Approaches to Thyroid Lobectomy: A Discrete Choice Experiment.
    Sukpanich R; Sanglestsawai S; Seib CD; Gosnell JE; Shen WT; Roman SA; Sosa JA; Duh QY; Suh I
    Thyroid; 2020 Sep; 30(9):1306-1313. PubMed ID: 32204688
    [No Abstract]   [Full Text] [Related]  

  • 8. A discrete-choice experiment to assess treatment modality preferences of patients with depression.
    Lokkerbol J; Geomini A; van Voorthuijsen J; van Straten A; Tiemens B; Smit F; Risseeuw A; Hiligsmann M
    J Med Econ; 2019 Feb; 22(2):178-186. PubMed ID: 30501437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the Heterogeneity in Women's Preferences for Breast Screening: Does the Communication of Risk Matter?
    Vass CM; Rigby D; Payne K
    Value Health; 2018 Feb; 21(2):219-228. PubMed ID: 29477404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Discrete Choice Analysis Comparing COVID-19 Vaccination Decisions for Children and Adults.
    Prosser LA; Wagner AL; Wittenberg E; Zikmund-Fisher BJ; Rose AM; Pike J
    JAMA Netw Open; 2023 Jan; 6(1):e2253582. PubMed ID: 36716030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient Preferences for Bariatric Surgery: Findings From a Survey Using Discrete Choice Experiment Methodology.
    Rozier MD; Ghaferi AA; Rose A; Simon NJ; Birkmeyer N; Prosser LA
    JAMA Surg; 2019 Jan; 154(1):e184375. PubMed ID: 30484820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
    Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
    Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients prioritize local recurrence risk over other attributes for surgical treatment of facial melanomas-Results of a stated preference survey and choice-based conjoint analysis.
    Etzkorn JR; Tuttle SD; Lim I; Feit EM; Sobanko JF; Shin TM; Neal DE; Miller CJ
    J Am Acad Dermatol; 2018 Aug; 79(2):210-219.e3. PubMed ID: 29505861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Change in Papillary Thyroid Cancer Terminology on Anxiety Levels and Treatment Preferences: A Randomized Crossover Trial.
    Nickel B; Barratt A; McGeechan K; Brito JP; Moynihan R; Howard K; McCaffery K
    JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):867-874. PubMed ID: 30335875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors That Inform Individual Decision Making Between Active Surveillance, Hemithyroidectomy and Total Thyroidectomy for Low-Risk Thyroid Cancer: A Scoping Review.
    Wei J; Thwin M; Nickel B; Glover A
    Thyroid; 2022 Jul; 32(7):807-818. PubMed ID: 35438545
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessment of patients' preferences for new anticancer drugs in China: a best-worst discrete choice experiment on three common cancer types.
    Feng Z; Meng J; Sun Y; Xie T; Lu W; Wang G; Geng J
    BMJ Open; 2023 Jun; 13(6):e072469. PubMed ID: 37270199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mimicking Real-Life Decision Making in Health: Allowing Respondents Time to Think in a Discrete Choice Experiment.
    Veldwijk J; Johansson JV; Donkers B; de Bekker-Grob EW
    Value Health; 2020 Jul; 23(7):945-952. PubMed ID: 32762997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Preferences for Metastatic Hormone-Sensitive Prostate Cancer Treatments: A Discrete Choice Experiment Among Men in Three European Countries.
    de Freitas HM; Ito T; Hadi M; Al-Jassar G; Henry-Szatkowski M; Nafees B; Lloyd AJ
    Adv Ther; 2019 Feb; 36(2):318-332. PubMed ID: 30617763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care: Shared Decision Making in Cancer Care.
    Kehl KL; Landrum MB; Arora NK; Ganz PA; van Ryn M; Mack JW; Keating NL
    JAMA Oncol; 2015 Apr; 1(1):50-8. PubMed ID: 26182303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany.
    Hofheinz R; Clouth J; Borchardt-Wagner J; Wagner U; Weidling E; Jen MH; Brück P
    BMC Cancer; 2016 Dec; 16(1):937. PubMed ID: 27923357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.